Press release

Orthofix to Participate in Upcoming Investor Conferences

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Massimo

articleOrthofix Medical Inc.October 15, 20255/company/orthofix-medical-inc/news/orthofix-participate-upcoming-investor-conferences-2025-10-15
Orthofix to Participate in Upcoming Investor Conferences

About this update from Orthofix Medical Inc.

[{"type":"text","content":" LEWISVILLE, Texas--(BUSINESS WIRE)--\nOrthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Massimo Calafiore, President and Chief Executive Officer, and Julie Andrews, Chief Financial Officer, will participate in the following investor conferences:\n\n\n\nUBS Global Healthcare Conference in Palm Beach Gardens, FL, November 11, 2025, at 1:15 pm Eastern Time\n\n\n\nStifel Healthcare Conference in New York, NY, November 12, 2025, at 10:00 am Eastern Time\n\n\n\nJefferies Global Healthcare Conference in London, UK, November 18-19, 2025, 1x1 meetings only\n\n\n\nInterested parties can access the live and archived webcast of the presentations in the “Events & Presentations” section of the Orthofix Investor Relations Website at ir.orthofix.com.\n\n\nInternet Posting of Information\n\n\nOrthofix regularly shares important updates in the “Investors” section of its website at www.orthofix.com. The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix.\n\n\nAbout Orthofix\n\n\nOrthofix is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, Orthofix delivers exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH™ Navigation System. To learn more, visit Orthofix.com and follow on LinkedIn.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20251015092881/en/\n\nCompany Contact:\n\n\nInvestors and Media\n\n\nJulie Dewey, IRC\nChief Investor Relations & Communications Officer\[email protected]\n209.613.6945\n\n\nSource: Orthofix Medical Inc.","length":4990,"tagName":"div"}]

More updates from Orthofix Medical Inc.